| 2026-09-01 | Press release | Biomerica Reports Fiscal 2026 Year-End Financial Results |
| 2026-08-31 | 10-K | Annual report on Form 10-K, FY26 |
| 2026-08-27 | Press release | Biomerica Announces $2.23 Million Financing |
| 2026-08-26 | 8-K | Form 8-K, Item 1.01 |
| 2026-06-04 | 8-K | Form 8-K, Item 1.01 |
| 2026-05-28 | Press release | Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development |
| 2026-04-29 | Press release | Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 |
| 2026-04-16 | Press release | Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening |
| 2026-04-14 | Press release | Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs |
| 2026-04-13 | Press release | Biomerica Reports Third Quarter Fiscal 2026 Financial Results |
| 2026-04-13 | 10-Q | Form 10-Q for the quarter ended Feb 28 |
| 2026-03-18 | Press release | Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laborator |
| 2026-03-05 | Press release | Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain |
| 2026-03-02 | Deck | Investor presentation · Mar 2026 |
| 2026-02-26 | Press release | Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achi |
| 2026-02-18 | Press release | Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution |
| 2026-02-01 | Deck | Investor presentation · Feb 2026 |
| 2026-01-14 | Press release | Biomerica Reports Second Quarter Fiscal 2026 Financial Results |
| 2026-01-14 | 10-Q | Form 10-Q for the quarter ended Nov 30 |
| 2025-12-16 | 8-K | Form 8-K, Item 5.07 |
| 2025-10-20 | Proxy | Definitive proxy statement |
| 2025-10-15 | Press release | Press release · Q1 2026 · Oct 2025 |
| 2025-10-14 | 10-Q | Form 10-Q for the quarter ended Aug 31 |
| 2025-10-08 | 8-K | Form 8-K, Item 5.02 |
| 2025-09-26 | 10-K | Annual report on Form 10-K/A, FY25 |
| 2025-08-29 | Press release | Press release · FY 2025 · Aug 2025 |
| 2025-08-29 | 10-K | Annual report on Form 10-K, FY25 |
| 2025-06-06 | 8-K | Form 8-K, Item 5.02 |
| 2025-04-16 | 8-K | Form 8-K, Item 3.03 |
| 2025-04-15 | Press release | Biomerica Reports Third Quarter Fiscal 2025 Financial Results |
| 2025-04-14 | 10-Q | Form 10-Q for the quarter ended Feb 28 |
| 2025-01-15 | Press release | Press release · Q2 2025 · Jan 2025 |
| 2025-01-14 | 10-Q | Form 10-Q for the quarter ended Nov 30 |
| 2024-12-17 | 8-K | Form 8-K, Item 5.07 |
| 2024-11-06 | 8-K | Form 8-K, Item 3.01 |
| 2024-10-16 | Press release | Biomerica Reports First Quarter Fiscal 2025 Financial Results |
| 2024-10-15 | 10-Q | Form 10-Q for the quarter ended Aug 31 |
| 2024-09-30 | Proxy | Definitive proxy statement |
| 2024-08-29 | Press release | Press release · FY 2024 · Aug 2024 |
| 2024-08-28 | 10-K | Annual report on Form 10-K, FY24 |